Diagnostic Device Company Doubles Manufacturing Capacity; Expands Global Reach with Vietnam Facility
FOUNTAIN VALLEY, Calif., April 13 /PRNewswire/ -- Alpine Biomed Corporation, a global leader in specialty diagnostic devices, announced today that it has doubled its manufacturing capacity and expanded its worldwide network by opening a new facility in Vietnam. The company will produce and distribute medical devices that are in increasing demand for diagnosing gastroesophageal reflux disease (GERD) from its new manufacturing facility located in HoChiMinh City.
The new facility is Alpine Biomed's latest investment to expand its products and capabilities. In January, the company acquired Stellate Systems Inc. to increase its neurodiagnostics business and boost its presence in the rapidly growing sleep diagnostics market. Since partnering in 2007 with Water Street Healthcare Partners, a leading private equity firm focused exclusively on the health care industry, Alpine Biomed has achieved record sales and revenue growth. It is projected to increase sales as much as 25 percent in 2009.
"Our new facility in Vietnam is another key component of our strategic plan to become one of the world's leading specialty diagnostic device companies," said Alpine Biomed President and CEO John Arnott. "It is a state-of-the-art facility featuring the most advanced technologies that connect our manufacturing centers around the world to provide our customers with the highest-quality devices that diagnose a range of gastrointestinal and neurological disorders."
Alpine Biomed's new facility is one of the first U.S.- headquartered companies in HoChiMinh City to receive Medical Device Quality Management System certification from the International Organization for Standardization (ISO). It also has been registered with the U.S. Food & Drug Administration (FDA). The manufacturing center will export diagnost
|SOURCE Alpine Biomed Corporation|
Copyright©2009 PR Newswire.
All rights reserved